abstract |
The present invention relates to compounds which bind to the NR1H4 receptor (FXR) and are useful as agonists of FXR. The invention further relates to the use of such compounds for the preparation of a medicament for the treatment of diseases and/or conditions via the binding of such compounds to the nuclear receptor, and to the synthesis of such compounds. |